Intercept Pharmaceuticals did a re-analysis of the
Post# of 148282
(Total Views: 616)
Posted On: 07/07/2022 4:23:46 PM
Intercept Pharmaceuticals did a re-analysis of the data from their fatty liver disease clinical trial, and guess what, they say it worked.
I can only imagine how cutting Adam Feuerstein will be about that, cuz, ya know anyone who re-analyzes data is clearly trying to make a failed clinical trial look good -- right?
Oh wait -- the positive article about the company is on..... the website he writes for -- and he wrote the article.
I can only imagine how cutting Adam Feuerstein will be about that, cuz, ya know anyone who re-analyzes data is clearly trying to make a failed clinical trial look good -- right?
Oh wait -- the positive article about the company is on..... the website he writes for -- and he wrote the article.
(3)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼